Improving quality of life of patients by developing novel medicines, with a special focus on cannabinoids as active ingredient.



Specialist in cannabinoid based medication.

Echo Pharmaceuticals (‘Echo’) is a privately owned specialized pharmaceutical company, with more than 10 years of experience, in leading innovation in advanced cannabis-based medicines and products. We are known for our first class experience in extraction, purification and formulation of lipoholic active compounds, particularly cannabinoids.

Using our patented knowledge on Drug Formulation, Alitra®, we formulate active compounds into the optimal pharmaceutical form for clinical investigations. Our development programs focus on a product portfolio of cannabinoid based medicines and drug delivery technologies, including the world’s first natural THC tablet, Namisol®.


Learn More
 
 

Reference standards

Echo Pharmaceuticals is an established supplier of a wide range of high quality cannabinoid reference standards for research and development purposes all around the globe. Our cannabinoid standards are accompanied by a Certificate of Analysis that guarantees the high quality of the products.

Image Image Image Image Image

Learn More about reference standards
Image
 

Our story/about us

Our mission is to develop effective medicines, with a focus on cannabinoid-based compounds, and drug delivery technologies that contribute to improve the quality of life for a wide range of patients. Our development programs focus on a product portfolio of cannabinoid based medicines and drug delivery technologies, including the novel lipophilic compound delivery technology Alitra®


More about us
 

Products


The product portfolio of
Echo Pharmaceuticals consists
of marketed products:


Reference standards

With the current growing demand for cannabinoids, we offer a wide range of high quality cannabinoid reference standards at competitive prices.


Active Pharmaceutical Ingredient (API)

Echo is specialized in the isolation of cannabinoids, with a focus on API production. These API’s are commercially available and are also used as active ingredients in our products in clinical development.

Products in Clincial Development:


Namisol®

Namisol® is the world’s first oral tablet that contains pure, natural Δ9-THC in fixed dosages with high, predictable bioavailability and a long, stable shelf life at room temperature.


Arvisol®

Arvisol tablet containing pure natural Cannabidiol (CBD) with predictable bioavailability.


 

Our products are consistently produced and controlled according to the high quality standards of GMP (Good Manufacturing Practice).

Image